Novonesis A/S (OTC:NVZMY - Get Free Report) shares were down 0.9% on Wednesday . The stock traded as low as $59.67 and last traded at $60.15. Approximately 6,255 shares were traded during trading, a decline of 68% from the average daily volume of 19,615 shares. The stock had previously closed at $60.69.
Novonesis A/S Trading Down 3.1 %
The business's fifty day simple moving average is $57.69. The firm has a market capitalization of $27.26 billion, a price-to-earnings ratio of 36.84, a price-to-earnings-growth ratio of 2.79 and a beta of 0.91.
Novonesis A/S Company Profile
(
Get Free Report)
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Recommended Stories
Before you consider Novonesis A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novonesis A/S wasn't on the list.
While Novonesis A/S currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
